Dr. Danielle Geraldi-Samara, MD

Dr. Geraldi-Samara practices at Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center.

Dr. Geraldi-Samara's NPI, 1770764110, was assigned on November 14, 2007. Dr. Geraldi-Samara graduated from SUNY Upstate Medical University in 2003. Dr. Geraldi-Samara's New York license number on file is 240518.

Dr. Geraldi-Samara's primary practice is Richmond University Medical Center, at 355 Bard Avenue, Staten Island, NY 10310 in Richmond County. The practice phone is (718) 354-5047.

Dr. Geraldi-Samara's primary practice is Richmond University Medical Center in Staten Island, New York, part of Richmond University Medical Center. Dr. Geraldi-Samara is also affiliated with Staten Island University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Geraldi-Samara to 6 more medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geraldi-Samara practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Geraldi-Samara's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Geraldi-Samara is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Geraldi-Samara's licenses on file in 15 states: New York, Washington, Colorado, Florida, Michigan, New Mexico, Ohio, South Carolina, Alaska, California, District of Columbia, Georgia, Hawaii, Iowa and Idaho.

Dmand AI lists non-alzheimer's dementia (chronic) among the conditions Dr. Geraldi-Samara treats.

CMS data shows 755 Medicare services from Dr. Geraldi-Samara across 11 procedure codes in 2024, for 149 Medicare patients. Medicare paid $59,218 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Geraldi-Samara in 2024. The largest group is 65 to 74, with 59 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Geraldi-Samara's median patient age at 62, with 64% women.

In 2024, Dr. Geraldi-Samara wrote 849 Medicare Part D claims for 131 patients. 74% of them were for generic drugs. CMS names the drug for 673 of them, across 18 drugs with 11 or more claims each, at $1,773,668 in total drug cost. In 2023, CMS named 136 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Geraldi-Samara for performance year 2024, reported through an alternative payment model (APM). Dr. Geraldi-Samara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Geraldi-Samara as offering telehealth.

Dmand AI links 2 papers to Dr. Geraldi-Samara in 2018. Dr. Geraldi-Samara's most frequent co-author is Natarajan Elangovan, MD, MPH.

CMS Open Payments shows 4 general payments to Dr. Geraldi-Samara from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Eisai Inc. paid the most, $124.

Dmand AI lists 1 award for Dr. Geraldi-Samara.

Dr. Geraldi-Samara graduated from SUNY Upstate Medical University in 2003. Dr. Geraldi-Samara is a member of AAN.

Dr. Geraldi-Samara is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.